Angiogenesis in vulvar intraepithelial neoplasia

Gynecologic Oncology

Volumn 64, Issue 3, 1997, Pages 496-500

  Bancher Todesca, Dagmar ^a   Obermair, Andreas ^a   Bilgi, Selcuk ^a   Kohlberger, Petra ^a   Kainz, Christian ^a   Breitenecker, Gerhard ^a   Leodolter, Sepp ^a   Gitsch, Gerald ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER INVASION; CARCINOMA IN SITU; CELL POPULATION; CELL PROLIFERATION; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; TUMOR GROWTH; VASCULARIZATION; VULVA CARCINOMA;

EID: 0031105651     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4582     Document Type: Article

References (31)

1. 1. Folkman J: Tumor Angiogenesis, in The Molecular Basis of Cancer. (J. Mendelsohn, P. M. Howley, M. A. Israel, and L. A. Liotta (Eds.), Saunders, Philadelphia, 1995, pp. 206-232
2. 2. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186 1971
3. 3. Gimbrone MA, Leapman SB, Cotran RS, Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261-276 1972
4. 4. Kim KJ, Li B, Winer J, Armani M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumor growth in vivo. Nature 362:5822-5827 1993
5. 5. Millauer B, Shawyer LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 364:576-579 1994
6. 6. Baillie CT, Winslet MC, Bradley NJ: Tumor vasculature-A potential therapeutic target. Br J Cancer 72:257-267 1995
7. 7. Leung DW, Cachianes G, Kuang W, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309 1989
8. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774-1778 1990
9. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138:213-221 1991
10. 10. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR: The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci 752:246-256 1995
11. 11. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039 1995
12. 12. Jones RW, Rowan DM: Vulvar intraepithelial neoplasia III: A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 84:741-745 1994
13. 13. Hording U, Junge J, Daugaard S, Lundvall F, Poulsen H Bock J: Vulvar squamous cell carcinoma and papillomaviruses: Indications for two different etiologies. Gynecol Oncol 52:241-246 1994
14. 14. Kurman RJ, Norris HJ, Wilkinson EJ: Tumors of the Vulva, in Atlas of Tumor Pathology: Tumors of the Cervix, Vagina, and Vulva. (Kurman RJ, Norris HJ, Wilkinson EJ (eds): Washington, DC, Armed Forces Institute of Pathology, 1992, pp 179-255
15. 15. Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsch G, Sevelda P: Microvessel density and vessel invasion in lymphnode negative breast cancer: Effect on recurrence-free survival. Int J Cancer 62:126-131 1995
16. 16. Kendall MG: Rank Correlation Methods: 4th ed., London, Griffin, 1970
17. 17. Deen S, Ball RY: Basement membrane and extracellular interstitial matrix components in bladder neoplasia-Evidence of angiogenesis. Histopathology 25:475-481 1994
18. 18. Brem S, Gullino PM: Angiogenesis: A marker for neoplastic transformation of mammary papillary hyperplasia. Science 195:880-882 1977
19. 19. Brem S, Jensen HM, Gullino PM: Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239-244 1978
20. 20. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61 1989
21. 21. Smith-McKune K, Weidner N: Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800-804 1994
22. 22. Lee AK: Basement Membrane and Endothelial Agents: Their Role in Evaluation of Tumor Invasion and Metastasis, in De Ellis RA (Ed): Advances in Immunohistochemistry, New York, Raven Press, 1988, pp 363-393
23. 23. Weidner N: Intratumoral micro vessel density as a prognostic factor in cancer. Am J Pathol 147:9-19 1995
24. 24. Zhang HT, Craft P, Scott PA, Ziehe M, Weich HA, Harris AL, Bicknell R: Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87:213-219 1995
25. 25. Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85:1045-1049 1994
26. 26. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968 1995
27. 27. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy J, Sotrel A, Manseau EJ, Van De Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 174:1275-1278 1991
28. 28. Qu-Hong Nagy JA, Senger DR, Dvorak HF, Dvorak AM: Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor micro vascular endothelium. J Histochem Cytochem 43:381-389 1995
29. 29. Kataja V, Syrjänen S, Mäntyjärvi R, Yliskoski M, Saarikoski S, Syrjänen K: Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis 19:154-160 1992
30. 30. Hellberg D, Nilson S, Grad A, Hongxiu J, Fuju C, Syrjänen S, Syrjänen K: Behaviour of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types. Arch Gynecol Obstet 252:119-128 1993
31. 31. Meyskens FL Jr, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS, Alberts DS: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: A randomized trial. J Natl Cancer Inst 86:539-543 1994